Ocular Drug Delivery Technology Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : May-2020 | List of Tables : 42 | List of Figures : 94 | No. of Pages : 170 | Report Code : FACT4802MR | Format :

Global Ocular Drug Delivery Technology Market Insights:

Limited bioavailability of drugs in conventional ocular therapeutics shall spur research in developing advanced drug delivery techniques for ophthalmic administration. Studies have shown that micellar formulations can help improve bioavailability of drugs in ocular tissues. This shall translate in enhanced therapeutic outcomes. Further, Studies indicate that the number of glaucoma patients is anticipated to rise to 111.8 million by 2040. Based on the aforementioned trends, the global ocular drug delivery technology market is poised to leverage positively at a CAGR of 7.2% during the forecast period (2020-2025).

Global Ocular Drug Delivery Technology Market Technological Insights: Topical drug delivery technology accounted for more than half of the total ocular drug delivery market in 2017. This trend is anticipated to continue, with the topical segment capturing a similar proportion of the overall market. A valuation of US$ 9 Bn is predicted by 2025. Introduction of emulsion and suspension forms in the formulation of topical drug delivery technologies is a major growth driver. Moreover, the technique is also very cost-effective. The topical segment is poised to expand 1.4x throughout the forecast period.

Following behind topical drug delivery is the intraocular implants segment. High adoption of intraocular implants due to its targeted action and long-term effectiveness have boosted growth opportunities for this technology. A market share of more than one-tenth is anticipated for intraocular implants, expanding at a CAGR of 7.7% across the forecast period. The segment is poised to reach a value of US$ 3 Bn by 2025-end.

Global Ocular Drug Delivery Technology Market Formulation Insights: Augmenting demand for targeted drug delivery, especially for posterior eye disorders, and high penetration of low molecular size particles shall leverage market prospects for liposome and nanoparticle formulations. Moreover, nanoparticles are claimed to provide prolonged resistance time on the ocular surface. A CAGR of 8.2% is anticipated for the liposome and nanoparticle segment, reaching a value of US$ 1 Bn by 2025-end.

The solutions segment is set to retain its market dominance across the forecast period. Dominance of the segment is attributed to its large production volume by small players in regional markets. Moreover, high-patient compliance and cost-effectiveness are other growth contributors. Projections indicate a market share exceeding three-fifths and an expansion rate of 1.4x in the forecast period.

ocular drug delivery technology market size and growth forecast

To get the latest COVID-19 impact insights on the ocular drug delivery technology, ask an analyst here

Global Ocular Drug Delivery Technology Market Regional Insights:

North America is poised to retain hegemony in the global ocular drug delivery technology market. Burgeoning cases of visual impairments, high cost of ocular surgeries and presence of a large number of market players are anticipated to boost the North American market. Projections indicate a market share exceeding half of the total ocular drug delivery technology market. In addition, introduction of different formulation types and reduced research and development costs are also poised to leverage growth prospects. The North American market is anticipated to expand 1.4x during the forecast period.

Asia-Pacific is expected to generate credible growth opportunities in the future. Establishment of research and development units by key manufacturers in emerging economies, increasing prevalence of cataract and uveitis are key growth levers. Research grants are being advanced by major research companies across several Asia-Pacific countries, thus broadening the scope of drug development. The Asia-Pacific region is poised to expand at a CAGR of 7.0% throughout the forecast period, capturing nearly 1/10th of the total market share.

ocular drug delivery technology market share forecast by region

To get detailed insights on the ocular drug delivery technology market, request for a report sample here

Global Ocular Drug Delivery Technology Market Key Players

The global ocular drug delivery market is consolidated, consisting of a limited number of market players. However, the market is poised to become fragmented, owing to collaboration and acquisition strategies adopted by leading players. The prominent market players are Ocular Therapeutix, Inc., Alimera Sciences, Allergan plc, Valeant Pharmaceuticals International (Bausch Health Company), Inc., and Santen Pharmaceutical Co., Ltd. Specific research and development in ocular drug delivery technologies is an important approach adopted by the leading market players.

Valeant Pharmaceuticals (Bausch & Lomb, Inc.) is a leader in the ocular drug delivery market. It specializes in a number of ophthalmic drugs for a number of conditions. These include glaucoma, conjunctivitis, uveitis and cataracts. Its brands are Bepreve, Istalol, Besivance, Alrex and Zylet. In 2017, the company announced the introduction of Biotrue ONEday, daily disposable contact lenses for Astigmatism. Another market leader, Santen pharmaceuticals, specializes in corneal and retinal diseases such as Dry Eyes, Uveitis, AMD and Diabetic Retinopathy, and Glaucoma. Its products include Tafluprost, Ciclosporin, Sepetaprost and Carotuximab.

COVID-19 Market Insights:

The outbreak of the COVID-19 pandemic has posed significant challenges to the healthcare industry across the globe. As the number of cases rise exponentially every day, key market players are increasingly diverting research and funding towards eradicating this deadly pandemic. This is anticipated to lead to shortfalls in the core business line. However, companies are putting their best feet forward to ensure that supply chains are not disrupted.

Santen pharmaceuticals, a prominent ocular drug player, is ensuring that there is continuous treatment delivery for visually impaired patients. Maintenance of appropriate inventory standards of intermediaries and raw materials is an important step in this regard. Moreover, production plants have been sterilized so that the infection does not spread among factory workers. Thorough body temperature checks along with social distancing are being practiced in the company’s factories. People who are not engaged in production activity are encouraged to work from home. Furthermore, all employees have been strongly discouraged to travel abroad for work.

Another market player, Graybug Vision, has directed its patients who are enrolled in clinical studies to restrict their in-clinic time to reduce exposure risk. Since most of the subjects are elderly patients, this precaution is absolutely important. This is anticipated to lead to substantial delays in drug development for visual disorders.

Analyst’s Viewpoint:

The global ocular drug delivery market shall witness positive growth in the future. Technological breakthroughs in the form of novel drug formulations for precise ophthalmic treatment is are poised to leverage the market. However, the ongoing COVID-19 pandemic shall substantially impede progress, owing to reduced production and research capabilities. However, in the long-run, the market is set to rebound. North America and Asia-Pacific are poised to remain attractive markets for ocular drug delivery. This is due to increasing research funding by the governments of the respective countries.

Global Ocular Drug Delivery Technology Market: Report Scope:

The study of the global ocular drug delivery technology market undertaken by Fact.MR, incorporates a five-year forecast period, 2020-2025. The report explicates on the key drivers, restraints and opportunities associated with ocular drug delivery. The market has been segmented on the basis of technology type, formulation type, disease type and end-user. Each segment is evaluated in terms of market share, revenue, attractiveness index and growth.

A detailed regional profiling has also been done, incorporating all of the abovementioned segments. The profiling is done for the following geographies: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. In addition, a detailed competition landscape, highlighting key manufacturers’ revenue share, expansion strategies and product launches, have also been embedded within the report. Each company is also provided with a SWOT analysis to provide a realistic picture for future expansion.

Global Ocular Drug Delivery Technology Market- Scope of the Report

The recent study by Fact.MR on global ocular drug delivery technology market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends currently determining the growth of the global ocular drug delivery technology market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders and emerging players associated with the provision of global ocular drug delivery technology. The study also provides dynamics responsible for influencing the future status of the global ocular drug delivery technology market over the forecast period.

A detailed assessment of the global ocular drug delivery technology market’s value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global ocular drug delivery technology market along with their product portfolio enhances the reliability of this comprehensive research study.

Global Ocular Drug Delivery Technology Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the global ocular drug delivery technology market across the globe.

A comprehensive estimate on the global ocular drug delivery technology market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of global ocular drug delivery technology market during the forecast period.

Global Ocular Drug Delivery Technology Market Segmentation

Fact.MR has studied the global ocular drug delivery technology market with detailed segmentation on the basis of technology type, formulation type, disease type, end-user and region.

Technology Type

Formulation Type

Disease Type

End-user

Region

Topical

Solution

Glaucoma

Hospitals

North America

Ocular Inserts:

Non-erodible

Erodible

Suspension

Diabetic Retinopathy

Ambulatory Surgical Centers

Europe

Iontophoresis

Emulsion

Dry Eye Syndrome

Ophthalmic Clinics

Asia Pacific

Intraocular Implants:

Biodegradable

Non-biodegradable

Liposomes & Nanoparticles

Macular Degeneration

Homecare Settings

Latin America

In-Situ Gel & Punctal Plugs

Ointment

Diabetic Macular Edema

 

Middle East & Africa

Others

 

Cataract

 

 

 

 

Others

 

 

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Global Ocular Drug Delivery Technology Market: Analysis on Market Size Evaluation

The global ocular drug delivery technology market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for global ocular drug delivery technology market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent global ocular drug delivery technology market segments, along with market attractiveness evaluation has been incorporated in the report.

Global Ocular Drug Delivery Technology Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global ocular drug delivery technology report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the global ocular drug delivery technology market during the forecast period.

Country-specific valuation on demand for global ocular drug delivery technology has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

Global Ocular Drug Delivery Technology Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of global ocular drug delivery technology products along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of global ocular drug delivery technology products, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, such as product portfolio, key strategies along with an all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global ocular drug delivery technology market. Prominent manufacturers with established market presence in the global ocular drug delivery technology market are Ocular Therapeutix, Inc., Alimera Sciences, Allergan plc, Valeant Pharmaceuticals International (Bausch Health Company), Inc., and Santen Pharmaceutical Co., Ltd.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ocular Drug Delivery Disease Type Market

4. Market Overview

    4.1. Introduction

        4.1.1. Disease Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Key Market Indicators

        4.3.1. Region/Country Specific

        4.3.2. Product/Application/Disease Type Specific

        4.3.3. Target Market Specific – Global Scenario

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunity

    4.5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, 2020–2025

    4.6. Ocular Drug Delivery Disease Type Market - Global Supply Demand Scenario

    4.7. Porter’s Five Force Analysis

    4.8. Market Outlook

    4.9. Ocular Drug Delivery Technology: Pipeline Analysis

5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market Value Forecast By Disease Type, 2020–2025

        5.4.1. Topical

        5.4.2. Ocular Insert

            5.4.2.1. Erodible

            5.4.2.2. Non-Erodible

        5.4.3. Iontophoresis

        5.4.4. Intraocular Implant

            5.4.4.1. Biodegradable 

            5.4.4.2. Non-Biodegradable

        5.4.5. In Situ Gel & Punctal Plug

        5.4.6. Others

    5.5. Market Attractiveness By Disease Type 

6. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Formulation Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market Value Forecast By Formulation Type, 2020–2025

        6.4.1. Solution

        6.4.2. Suspension

        6.4.3. Emulsion

        6.4.4. Liposomes & Nanoparticles

        6.4.5. Ointments

    6.5. Market Attractiveness By Formulation Type 

7. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Key Trends

    7.4. Market Value Forecast By Disease Type , 2020–2025

        7.4.1. Diabetic Retinopathy

        7.4.2. Macular Degeneration

        7.4.3. Cataract

        7.4.4. Glaucoma

        7.4.5. Diabetic Macular Edema

        7.4.6. Dry Eye Syndrome

        7.4.7. Others

    7.5. Market Attractiveness By Disease Type 

8. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By End User 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Key Trends

    8.4. Market Value Forecast By End User, 2020–2025

        8.4.1. Hospitals

        8.4.2. Ambulatory Surgical Centers

        8.4.3. Ophthalmic Clinics

        8.4.4. Homecare Settings

    8.5. Market Attractiveness By End User 

9. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Region

    9.1. Key Findings

    9.2. Policies and Regulations

    9.3. Market Value Forecast By Region

        9.3.1. North America 

        9.3.2. Europe 

        9.3.3. Asia Pacific 

        9.3.4. Latin America 

        9.3.5. Middle East & Africa 

    9.4. Market Attractiveness By Country/Region

10. North America Ocular Drug Delivery Disease Type Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

        10.1.2. Policies and Regulations

        10.1.3. Price Trend Analysis

        10.1.4. Key Trends

    10.2. Market Value Forecast By Disease Type, 2020–2025

        10.2.1. Topical

        10.2.2. Ocular Insert

            10.2.2.1. Erodible

            10.2.2.2. Non-Erodible

        10.2.3. Iontophoresis

        10.2.4. Intraocular Implant

            10.2.4.1. Biodegradable 

            10.2.4.2. Non-Biodegradable

        10.2.5. In Situ Gel & Punctal Plug

        10.2.6. Others

    10.3. Market Value Forecast By Formulation Type, 2020–2025

        10.3.1. Solution

        10.3.2. Suspension

        10.3.3. Emulsion

        10.3.4. Liposomes & Nanoparticles

        10.3.5. Ointments

    10.4. Market Value Forecast By Disease Type, 2020–2025

        10.4.1. Diabetic Retinopathy

        10.4.2. Macular Degeneration

        10.4.3. Cataract

        10.4.4. Glaucoma

        10.4.5. Diabetic Macular Edema

        10.4.6. Dry Eye Syndrome

        10.4.7. Others

    10.5. Market Value Forecast By End User, 2020–2025

        10.5.1. Hospitals

        10.5.2. Ambulatory Surgical Centers

        10.5.3. Ophthalmic Clinics

        10.5.4. Homecare Settings

    10.6. Market Value Forecast By Country, 2020–2025

        10.6.1. U.S.

        10.6.2. Canada

    10.7. Market Attractiveness Analysis 

        10.7.1. By Disease Type 

        10.7.2. By Formulation Type 

        10.7.3. By Disease Type 

        10.7.4. By End User 

        10.7.5. By Country

11. Europe Ocular Drug Delivery Disease Type Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

        11.1.2. Policies and Regulations

        11.1.3. Price Trend Analysis

        11.1.4. Key Trends

    11.2. Market Value Forecast By Disease Type, 2020–2025

        11.2.1. Topical

        11.2.2. Ocular Insert

            11.2.2.1. Erodible

            11.2.2.2. Non-Erodible

        11.2.3. Iontophoresis

        11.2.4. Intraocular Implant

            11.2.4.1. Biodegradable 

            11.2.4.2. Non-Biodegradable

        11.2.5. In Situ Gel & Punctal Plug

        11.2.6. Others

    11.3. Market Value Forecast By Formulation Type, 2020–2025

        11.3.1. Solution

        11.3.2. Suspension

        11.3.3. Emulsion

        11.3.4. Liposomes & Nanoparticles

        11.3.5. Ointments

    11.4. Market Value Forecast By Disease Type, 2020–2025

        11.4.1. Diabetic Retinopathy

        11.4.2. Macular Degeneration

        11.4.3. Cataract

        11.4.4. Glaucoma

        11.4.5. Diabetic Macular Edema

        11.4.6. Dry Eye Syndrome

        11.4.7. Others

    11.5. Market Value Forecast By End User, 2020–2025

        11.5.1. Hospitals

        11.5.2. Ambulatory Surgical Centers

        11.5.3. Ophthalmic Clinics

        11.5.4. Homecare Settings

    11.6. Market Value Forecast By Country, 2020–2025

        11.6.1. U.K.

        11.6.2. Germany

        11.6.3. France

        11.6.4. Italy

        11.6.5. Russia

        11.6.6. Spain

        11.6.7. Rest of Europe

    11.7. Market Attractiveness Analysis

        11.7.1. By Disease Type 

        11.7.2. By Formulation Type 

        11.7.3. By Disease Type 

        11.7.4. By End User 

        11.7.5. By Country

12. Asia Pacific Ocular Drug Delivery Disease Type Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

        12.1.2. Policies and Regulations

        12.1.3. Price Trend Analysis

        12.1.4. Key Trends

    12.2. Market Value Forecast By Disease Type, 2020–2025

        12.2.1. Topical

        12.2.2. Ocular Insert

            12.2.2.1. Erodible

            12.2.2.2. Non-Erodible

        12.2.3. Iontophoresis

        12.2.4. Intraocular Implant

            12.2.4.1. Biodegradable 

            12.2.4.2. Non-Biodegradable

        12.2.5. In Situ Gel & Punctal Plug

        12.2.6. Others

    12.3. Market Value Forecast By Formulation Type, 2020–2025

        12.3.1. Solution

        12.3.2. Suspension

        12.3.3. Emulsion

        12.3.4. Liposomes & Nanoparticles

        12.3.5. Ointments

    12.4. Market Value Forecast By Disease Type, 2020–2025

        12.4.1. Diabetic Retinopathy

        12.4.2. Macular Degeneration

        12.4.3. Cataract

        12.4.4. Glaucoma

        12.4.5. Diabetic Macular Edema

        12.4.6. Dry Eye Syndrome

        12.4.7. Others

    12.5. Market Value Forecast By End User, 2020–2025

        12.5.1. Hospitals

        12.5.2. Ambulatory Surgical Centers

        12.5.3. Ophthalmic Clinics

        12.5.4. Homecare Settings

    12.6. Market Value Forecast By Country, 2020–2025

        12.6.1. China

        12.6.2. Japan

        12.6.3. India

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Market Attractiveness Analysis 

        12.7.1. By Disease Type 

        12.7.2. By Formulation Type 

        12.7.3. By Disease Type 

        12.7.4. By End User 

        12.7.5. By Country

13. Latin America Ocular Drug Delivery Disease Type Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

        13.1.2. Policies and Regulations

        13.1.3. Price Trend Analysis

        13.1.4. Key Trends

    13.2. Market Value Forecast By Disease Type, 2020–2025

        13.2.1. Topical

        13.2.2. Ocular Insert

            13.2.2.1. Erodible

            13.2.2.2. Non-Erodible

        13.2.3. Iontophoresis

        13.2.4. Intraocular Implant

            13.2.4.1. Biodegradable 

            13.2.4.2. Non-Biodegradable

        13.2.5. In Situ Gel & Punctal Plug

        13.2.6. Others

    13.3. Market Value Forecast By Formulation Type, 2020–2025

        13.3.1. Solution

        13.3.2. Suspension

        13.3.3. Emulsion

        13.3.4. Liposomes & Nanoparticles

        13.3.5. Ointments

    13.4. Market Value Forecast By Disease Type, 2020–2025

        13.4.1. Diabetic Retinopathy

        13.4.2. Macular Degeneration

        13.4.3. Cataract

        13.4.4. Glaucoma

        13.4.5. Diabetic Macular Edema

        13.4.6. Dry Eye Syndrome

        13.4.7. Others

    13.5. Market Value Forecast By End User, 2020–2025

        13.5.1. Hospitals

        13.5.2. Ambulatory Surgical Centers

        13.5.3. Ophthalmic Clinics

        13.5.4. Homecare Settings

    13.6. Market Value Forecast By Country, 2020–2025

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Market Attractiveness Analysis 

        13.7.1. By Disease Type 

        13.7.2. By Formulation Type 

        13.7.3. By Disease Type 

        13.7.4. By End User 

        13.7.5. By Country

14. Middle East & Africa Ocular Drug Delivery Disease Type Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

        14.1.2. Policies and Regulations

        14.1.3. Price Trend Analysis

        14.1.4. Key Trends

    14.2. Market Value Forecast By Disease Type, 2020–2025

        14.2.1. Topical

        14.2.2. Ocular Insert

            14.2.2.1. Erodible

            14.2.2.2. Non-Erodible

        14.2.3. Iontophoresis

        14.2.4. Intraocular Implant

            14.2.4.1. Biodegradable 

            14.2.4.2. Non-Biodegradable

        14.2.5. In Situ Gel & Punctal Plug

        14.2.6. Others

    14.3. Market Value Forecast By Formulation Type, 2020–2025

        14.3.1. Solution

        14.3.2. Suspension

        14.3.3. Emulsion

        14.3.4. Liposomes & Nanoparticles

        14.3.5. Ointments

    14.4. Market Value Forecast By Disease Type, 2020–2025

        14.4.1. Diabetic Retinopathy

        14.4.2. Macular Degeneration

        14.4.3. Cataract

        14.4.4. Glaucoma

        14.4.5. Diabetic Macular Edema

        14.4.6. Dry Eye Syndrome

        14.4.7. Others

    14.5. Market Value Forecast By End User, 2020–2025

        14.5.1. Hospitals

        14.5.2. Ambulatory Surgical Centers

        14.5.3. Ophthalmic Clinics

        14.5.4. Homecare Settings

    14.6. Market Value Forecast By Country, 2020–2025

        14.6.1. GCC Countries

        14.6.2. South Africa

        14.6.3. Rest of Middle East and Africa

    14.7. Market Attractiveness Analysis 

        14.7.1. By Disease Type 

        14.7.2. By Formulation Type 

        14.7.3. By Disease Type 

        14.7.4. By End User 

        14.7.5. By Country

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis By Company (2015)

    15.3. Company Profiles 

        15.3.1. OCULAR THERAPEUTIX, INC. 

            15.3.1.1. Overview

            15.3.1.2. Financials

            15.3.1.3. Recent Developments

            15.3.1.4. Strategy

        15.3.2. Alimera Sciences

            15.3.2.1. Overview

            15.3.2.2. Financials

            15.3.2.3. Recent Developments

            15.3.2.4. Strategy

        15.3.3. Allergan, Plc 

            15.3.3.1. Overview

            15.3.3.2. Financials

            15.3.3.3. Recent Developments

            15.3.3.4. Strategy

        15.3.4. Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)

            15.3.4.1. Overview

            15.3.4.2. Financials

            15.3.4.3. Recent Developments

            15.3.4.4. Strategy

        15.3.5. EyeGate Pharma 

            15.3.5.1. Overview

            15.3.5.2. Financials

            15.3.5.3. Recent Developments

            15.3.5.4. Strategy

        15.3.6. Envisia Therapeutics 

            15.3.6.1. Overview

            15.3.6.2. Financials

            15.3.6.3. Recent Developments

            15.3.6.4. Strategy

        15.3.7. Clearside Biomedical, INC. 

            15.3.7.1. Overview

            15.3.7.2. Financials

            15.3.7.3. Recent Developments

            15.3.7.4. Strategy

        15.3.8. Graybug Vision Inc. 

            15.3.8.1. Overview

            15.3.8.2. Financials

            15.3.8.3. Recent Developments

            15.3.8.4. Strategy

        15.3.9. Santen Pharmaceutical Co., Ltd 

            15.3.9.1. Overview

            15.3.9.2. Financials

            15.3.9.3. Recent Developments

            15.3.9.4. Strategy

        15.3.10. Taiwan Liposome Company, Ltd

            15.3.10.1. Overview

            15.3.10.2. Financials

            15.3.10.3. Recent Developments

            15.3.10.4. Strategy

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Ocular Drug Delivery Technology Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025